Timing of drotrecogin alfa (activated) treatment in severe sepsis

Goda Choi; Anne-Cornélie JM de Pont; Marcus J Schultz

doi:10.1186/cc5010

Timing of drotrecogin alfa (activated) treatment in severe sepsis

Goda Choi, Anne-Cornélie JM de Pont, Marcus J Schultz

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

24 Downloads (Pure)

Original language	English
Article number	419
Number of pages	2
Journal	Critical care (London, England)
Volume	10
Issue number	4
DOIs	https://doi.org/10.1186/cc5010
Publication status	Published - 2006
Externally published	Yes

Keywords

Drug Administration Schedule
Humans
Protein C
Recombinant Proteins
Sepsis
Systemic Inflammatory Response Syndrome
Time Factors

Access to Document

10.1186/cc5010Licence: CC BY

Timing of drotrecogin alfaFinal publisher's version, 104 KBLicence: CC BY

Cite this

@article{62b725504ea44894877c292d07a28154,

title = "Timing of drotrecogin alfa (activated) treatment in severe sepsis",

keywords = "Drug Administration Schedule, Humans, Protein C, Recombinant Proteins, Sepsis, Systemic Inflammatory Response Syndrome, Time Factors",

author = "Goda Choi and {de Pont}, {Anne-Corn{\'e}lie JM} and Schultz, {Marcus J}",

year = "2006",

doi = "10.1186/cc5010",

language = "English",

volume = "10",

journal = "Critical Care",

issn = "1466-609X",

publisher = "BMC",

number = "4",

}

TY - JOUR

T1 - Timing of drotrecogin alfa (activated) treatment in severe sepsis

AU - Choi, Goda

AU - de Pont, Anne-Cornélie JM

AU - Schultz, Marcus J

PY - 2006

Y1 - 2006

KW - Drug Administration Schedule

KW - Humans

KW - Protein C

KW - Recombinant Proteins

KW - Sepsis

KW - Systemic Inflammatory Response Syndrome

KW - Time Factors

U2 - 10.1186/cc5010

DO - 10.1186/cc5010

M3 - Letter

C2 - 16934134

VL - 10

JO - Critical Care

JF - Critical Care

SN - 1466-609X

IS - 4

M1 - 419

ER -